HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients.

Abstract
To fully decipher the immunogenicity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike protein, it is essential to assess which part is highly immunogenic in a systematic way. We generate a linear epitope landscape of the Spike protein by analyzing the serum immunoglobulin G (IgG) response of 1,051 coronavirus disease 2019 (COVID-19) patients with a peptide microarray. We reveal two regions rich in linear epitopes, i.e., C-terminal domain (CTD) and a region close to the S2' cleavage site and fusion peptide. Unexpectedly, we find that the receptor binding domain (RBD) lacks linear epitope. We reveal that the number of responsive peptides is highly variable among patients and correlates with disease severity. Some peptides are moderately associated with severity and clinical outcome. By immunizing mice, we obtain linear-epitope-specific antibodies; however, no significant neutralizing activity against the authentic virus is observed for these antibodies. This landscape will facilitate our understanding of SARS-CoV-2-specific humoral responses and might be useful for vaccine refinement.
AuthorsYang Li, Ming-Liang Ma, Qing Lei, Feng Wang, Wei Hong, Dan-Yun Lai, Hongyan Hou, Zhao-Wei Xu, Bo Zhang, Hong Chen, Caizheng Yu, Jun-Biao Xue, Yun-Xiao Zheng, Xue-Ning Wang, He-Wei Jiang, Hai-Nan Zhang, Huan Qi, Shu-Juan Guo, Yandi Zhang, Xiaosong Lin, Zongjie Yao, Jiaoxiang Wu, Huiming Sheng, Yanan Zhang, Hongping Wei, Ziyong Sun, Xionglin Fan, Sheng-Ce Tao
JournalCell reports (Cell Rep) Vol. 34 Issue 13 Pg. 108915 (03 30 2021) ISSN: 2211-1247 [Electronic] United States
PMID33761319 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Antigens, Viral
  • Epitopes
  • Immunoglobulin G
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
Topics
  • Adult
  • Animals
  • Antibodies, Monoclonal (immunology)
  • Antibodies, Neutralizing (immunology)
  • Antibodies, Viral (immunology)
  • Antigens, Viral (immunology)
  • COVID-19 (epidemiology, genetics, immunology)
  • China (epidemiology)
  • Disease Models, Animal
  • Epitope Mapping (methods)
  • Epitopes (immunology)
  • Female
  • Humans
  • Immunoglobulin G (immunology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • SARS-CoV-2 (genetics, immunology)
  • Spike Glycoprotein, Coronavirus (genetics, immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: